Abingworth LLP
- SEC CIK
- 0001397144
- Latest filing
- Feb 10, 2023
Holdings in Q4 2021
Holdings as of Dec 31, 2021, filed Feb 16, 2022. Long positions only; changes compare share counts with Q3 2021.
- Positions
- 20
- 0 vs. Q3 2021
- Portfolio value
- $412.7M
- −$28.0M (−6.3%) vs. Q3 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| OCGNOcugen, Inc. | Common | 7,111 | $32.0K | <0.1% | 00.0% | Unchanged | History |
| OBSVObsEva SA | COM | 87,999 | $174.0K | <0.1% | 00.0% | Unchanged | History |
| CBAYCymaBay Therapeutics, Inc. | COM | 131,036 | $442.0K | 0.1% | 00.0% | Unchanged | History |
| MTEMMolecular Templates, Inc. | COM | 200,000 | $780.0K | 0.2% | 00.0% | Unchanged | History |
| SYRESpyre Therapeutics, Inc. | COM | 240,500 | $1.14M | 0.3% | 00.0% | Unchanged | History |
| XCURExicure, Inc. | COM | 6,977,000 | $1.40M | 0.3% | 00.0% | Unchanged | History |
| SLNOSoleno Therapeutics Inc | COM NEW | 10,302,602 | $4.22M | 1.0% | 00.0% | Unchanged | History |
| PRTKParatek Pharmaceuticals, Inc. | COM | 1,041,131 | $4.65M | 1.1% | 00.0% | Unchanged | History |
| NCNANuCana plc | SPONSORED ADR | 3,333,333 | $7.93M | 1.9% | 00.0% | Unchanged | History |
| Spruce BioE5209E109 | Common | 1,792,518 | $7.96M | 1.9% | 00.0% | Unchanged | – |
| SIENProject Sage Oldco, Inc. | COM | 2,349,827 | $8.60M | 2.1% | 00.0% | Unchanged | History |
| VRNAVerona Pharma plc | SPONSORED ADS | 2,457,499 | $16.3M | 4.0% | 00.0% | Unchanged | History |
| OKUROnKure Therapeutics, Inc. | COM | 2,073,957 | $17.7M | 4.3% | 00.0% | Unchanged | History |
| SRRASierra Oncology, Inc. | COM | 876,656 | $19.1M | 4.6% | 00.0% | Unchanged | History |
| PHATPhathom Pharmaceuticals, Inc. | COM | 1,203,135 | $23.6M | 5.7% | 00.0% | Unchanged | History |
| ACETAdicet Bio, Inc. | COM | 2,115,385 | $36.9M | 8.9% | +500,000+31.0% | Added | History |
| EFTReFFECTOR Therapeutics, Inc. | COM | 4,822,114 | $39.9M | 9.7% | 00.0% | Unchanged | History |
| JSPRJasper Therapeutics, Inc. | COM | 5,628,558 | $44.1M | 10.7% | 00.0% | Unchanged | History |
| VERAVera Therapeutics, Inc. | CL A | 2,960,231 | $78.5M | 19.0% | 00.0% | Unchanged | History |
| PCVXVaxcyte, Inc. | COM | 4,168,718 | $99.2M | 24.0% | 00.0% | Unchanged | History |